Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
This includes comprehensive molecular simulations of the receptor in its native membrane environment, paired with ensemble virtual screening that factors in its conformational mobility. In cases involving dimeric or oligomeric receptors, the entire functional complex is modelled, pinpointing potential binding pockets on and between the subunits to capture the full range of mechanisms of action.
Key features that set our library apart include:
partner
Reaxense
upacc
P11473
UPID:
VDR_HUMAN
Alternative names:
1,25-dihydroxyvitamin D3 receptor; Nuclear receptor subfamily 1 group I member 1
Alternative UPACC:
P11473; B2R5Q1; G3V1V9; Q5PSV3
Background:
The Vitamin D3 receptor, also known as the 1,25-dihydroxyvitamin D3 receptor or Nuclear receptor subfamily 1 group I member 1, is a pivotal nuclear receptor that mediates the effects of vitamin D3. It functions by binding to vitamin D3, entering the nucleus, and forming heterodimers with the retinoid X receptor. These complexes then bind to DNA, activating the transcription of genes involved in calcium homeostasis and response to vitamin D3.
Therapeutic significance:
The Vitamin D3 receptor plays a crucial role in Rickets vitamin D-dependent 2A, a disorder characterized by severe rickets, hypocalcemia, and secondary hyperparathyroidism, often accompanied by total alopecia. Understanding the role of the Vitamin D3 receptor could open doors to potential therapeutic strategies for this and related disorders.